For more than 30 years, NTD Eurofins has pioneered the research and development of prenatal screening protocols for open neural tube defects, Down syndrome, Trisomy 18/13 and early onset preeclampsia. NTD Eurofins processes hundreds of thousands of maternal blood specimens each year. Using specially designed analytical workflow cycles and immunoassay systems that ensure accurate testing and documentation, and efficient specimen handling and reporting, NTD provides risk assessment services that help health care professionals and patients make more informed medical decisions. Utilizing our Eurofins national network of laboratories, NTD is also able to offer advanced genetic testing for our customers, providing a full suite of women’s healthcare testing options.
NTD is a part of the Eurofins laboratory network. Eurofins Scientific is an international life sciences company which provides a unique range of analytical testing services to clients across multiple industries. As a world leader in food, environment, pharmaceutical and cosmetics products testing and in agroscience CRO services, our goal to contribute to a safer and healthier world by providing our customers with innovative and high-quality laboratory and advisory services whilst creating opportunities for our employees and generating sustainable shareholder value. Eurofins is also one of the global independent market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, advanced material sciences and for supporting clinical studies. In addition, Eurofins is one of the leading global emerging players in specialty clinical diagnostic testing.
